88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


CHANDO Group Presents 20 Research Papers at IFSCC 2026 Congress in Perth 12 years of participation underscore the Group's growing presence in global cosmetics science ... 2026-10-06T Biotechnology Cosmetics & Personal Care Household/Consumer/Cosmetics Medical/Pharmaceuticals
Fapon Showcases High-Performance IVD Raw Materials at JACLaS EXPO 2026 KOBE, Japan , Oct. 6, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider, will showcase its one-stop IVD solution at JACLaS EXPO 2026, held October 8–10 in Kobe, Japan. Visit Booth B32, Hall 1, ... 2026-10-06T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S. OMLYCLO ® (omalizumab-igec) is the first and only FDA-approved omalizumab biosimilar approved for all four indications of XOLAIR ® (omalizumab) and designated as interchangeable ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding development and manufacturing challenges TOKYO , Oct. 5, 2026 /PRNewswire/ -- ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea TAIPEI , Oct. 5, 2026 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with Yoo Young Pharm. Co., Ltd. ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care ... 2026-10-05T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA) The only known investigational therapy for SBMA in Phase 3 development worldwide ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MH WellFest Cambodia 2026 Marks a New Chapter in ASEAN Healthcare Connectivity PHNOM PENH, Cambodia , Oct. 5, 2026 /PRNewswire/ -- Maybank (Cambodia) Plc. and the Malaysia Healthcare Travel Council (MHTC) have concluded MH WellFest Cambodia 2026 at Borey Peng Huoth Eco ... 2026-10-05T Banking/Financial Service Health Care/Hospital Medical/Pharmaceuticals Travel
Celaid Therapeutics Completes Second Close of Series B Financing Round Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 ... 2026-10-05T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals